HKSH Offers In-House “Comprehensive Cancer Genomic Testing” Pairing Strengths in Molecular Genetics and Cytogenetics for Cancer Management

(20 May 2025, Hong Kong) Precision cancer treatment is based on accurate pathological diagnosis and cancer type classification. Harnessing advanced technologies and professional expertise at both genetic and chromosomal levels, The HKSH Cancer Centre (HKSH) is currently the only private medical institution in Hong Kong that offers comprehensive cancer genomic testing. By integrating Comprehensive Genomic Profiling (CGP), which identifies gene mutations, and Cytogenetics, which reveals chromosomal abnormalities, into clinical services, this dual approach offers critical insights into tumour pathogenesis. From diagnosis to treatment and even in cases of relapse, the use of CGP and cytogenetics not only enhances diagnostic accuracy and prognosis evaluation, but also allows doctors to tailor therapies, monitor treatment efficacy and drug resistance, achieving personalised precision medicine through the decoding of genes and chromosomes.

Please click here for more information.